Dr. Lal PathLabs informs about earnings call transcript

15 Nov 2021 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached Financial Results Conference Call Transcript of the Company for Q2 FY22.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

1390.10 14.75 (1.07%)
27-Jan-2026 11:05 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6765.25
Max Healthcare Inst 977.50
Narayana Hrudayalay 1723.75
Aster DM Healthcare 554.80
Global Health 1025.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×